Casdin Capital, LLC Diversified Active

Location: New York, NY

CIK: 0001534261 · Show all filings

Period: Q4 2015 (Next →)

Filing Date: Feb 8, 2016

Total Value: $113M (100.0% shares, 0.0% debt)

Holdings (31)

— BLUEPRINT MEDICINES CORP 9.6%

Value $10.87M Shares 412,500 Est. Cost $26.34 Unrealized —

— SAGE THERAPEUTICS INC 7.4%

Value $8.338M Shares 143,011 Est. Cost $58.30 Unrealized —

— LOXO ONCOLOGY INC 6.3%

Value $7.155M Shares 251,500 Est. Cost $28.45 Unrealized —

CTMX CYTOMX THERAPEUTICS INC 5.9%

Value $6.7M Shares 321,023 Est. Cost $15.82 Unrealized 0.0%

— SPARK THERAPEUTICS INC 5.8%

Value $6.57M Shares 145,000 Est. Cost $45.31 Unrealized —

— BLUEBIRD BIO INC 5.7%

Value $6.422M Shares 100,000 Est. Cost $64.22 Unrealized —

AGIO AGIOS PHARMACEUTICALS INC 5.5%

Value $6.265M Shares 96,500 Est. Cost $65.59 Unrealized 0.0%

— MYOKARDIA INC 5.2%

Value $5.921M Shares 403,872 Est. Cost $14.66 Unrealized —

— GENOMIC HEALTH INC 5.1%

Value $5.808M Shares 165,000 Est. Cost $35.20 Unrealized —

ILMN ILLUMINA INC 5.1%

Value $5.758M Shares 30,000 Est. Cost $161.39 Unrealized 0.0%

ALNY ALNYLAM PHARMACEUTICALS INC 5.0%

Value $5.648M Shares 60,000 Est. Cost $92.72 Unrealized 0.0%

— EPIZYME INC 4.7%

Value $5.327M Shares 332,500 Est. Cost $16.02 Unrealized —

VYGR VOYAGER THERAPEUTICS INC 4.6%

Value $5.187M Shares 236,862 Est. Cost $21.90 Unrealized —

ILMN ILLUMINA INC 3.4%

Value $3.839M Shares 20,000 Est. Cost $161.39 Unrealized 0.0%

BIIB BIOGEN INC 2.4%

Value $2.757M Shares 9,000 Est. Cost $287.35 Unrealized 0.0%

— FOUNDATION MEDICINE INC 2.1%

Value $2.422M Shares 115,000 Est. Cost $21.06 Unrealized —

— GENMARK DIAGNOSTICS INC 2.1%

Value $2.406M Shares 310,000 Est. Cost $7.76 Unrealized —

BMY BRISTOL MYERS SQUIBB CO 2.0%

Value $2.213M Shares 32,164 Est. Cost $46.69 Unrealized 0.0%

— GLOBAL BLOOD THERAPEUTICS IN 1.9%

Value $2.101M Shares 65,000 Est. Cost $32.32 Unrealized —

— INVITAE CORP 1.8%

Value $2.053M Shares 250,000 Est. Cost $8.21 Unrealized —

— KITE PHARMA INC 1.6%

Value $1.849M Shares 30,000 Est. Cost $61.63 Unrealized —

DXCM DEXCOM INC 1.2%

Value $1.392M Shares 17,000 Est. Cost $20.81 Unrealized 0.0%

— BLUEBIRD BIO INC 1.1%

Value $1.284M Shares 20,000 Est. Cost $64.22 Unrealized —

OSUR ORASURE TECHNOLOGIES INC 1.0%

Value $1.095M Shares 170,000 Est. Cost $5.71 Unrealized 0.0%

— OXFORD IMMUNOTEC GLOBAL PLC 0.8%

Value $863K Shares 75,000 Est. Cost $11.51 Unrealized —

— JUNO THERAPEUTICS INC 0.7%

Value $769K Shares 17,500 Est. Cost $43.94 Unrealized —

— ATARA BIOTHERAPEUTICS INC 0.6%

Value $660K Shares 25,000 Est. Cost $26.40 Unrealized —

— MEDIDATA SOLUTIONS INC 0.4%

Value $493K Shares 10,000 Est. Cost $49.30 Unrealized —

— TROVAGENE INC 0.3%

Value $378K Shares 70,000 Est. Cost $5.40 Unrealized —

AGIO AGIOS PHARMACEUTICALS INC 0.3%

Value $325K Shares 5,000 Est. Cost $65.59 Unrealized 0.0%

— FOUNDATION MEDICINE INC 0.3%

Value $316K Shares 15,000 Est. Cost $21.06 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	BLUEPRINT MEDICINES CORP	412,500	$10.87M	9.6%	$26.34	—	COM	09627Y109
—	SAGE THERAPEUTICS INC	143,011	$8.338M	7.4%	$58.30	—	COM	78667J108
—	LOXO ONCOLOGY INC	251,500	$7.155M	6.3%	$28.45	—	COM	548862101
CTMX	CYTOMX THERAPEUTICS INC	321,023	$6.7M	5.9%	$15.82	0.0%	COM	23284F105
—	SPARK THERAPEUTICS INC	145,000	$6.57M	5.8%	$45.31	—	COM	84652J103
—	BLUEBIRD BIO INC	100,000	$6.422M	5.7%	$64.22	—	COM	09609G100
AGIO	AGIOS PHARMACEUTICALS INC	96,500	$6.265M	5.5%	$65.59	0.0%	COM	00847X104
—	MYOKARDIA INC	403,872	$5.921M	5.2%	$14.66	—	COM	62857M105
—	GENOMIC HEALTH INC	165,000	$5.808M	5.1%	$35.20	—	COM	37244C101
ILMN	ILLUMINA INC	30,000	$5.758M	5.1%	$161.39	0.0%	COM	452327109
ALNY	ALNYLAM PHARMACEUTICALS INC	60,000	$5.648M	5.0%	$92.72	0.0%	COM	02043Q107
—	EPIZYME INC	332,500	$5.327M	4.7%	$16.02	—	COM	29428V104
VYGR	VOYAGER THERAPEUTICS INC	236,862	$5.187M	4.6%	$21.90	—	COM	92915B106
ILMN	ILLUMINA INC	20,000	$3.839M	3.4%	$161.39	0.0%	Call	452327109
BIIB	BIOGEN INC	9,000	$2.757M	2.4%	$287.35	0.0%	COM	09062X103
—	FOUNDATION MEDICINE INC	115,000	$2.422M	2.1%	$21.06	—	COM	350465100
—	GENMARK DIAGNOSTICS INC	310,000	$2.406M	2.1%	$7.76	—	COM	372309104
BMY	BRISTOL MYERS SQUIBB CO	32,164	$2.213M	2.0%	$46.69	0.0%	COM	110122108
—	GLOBAL BLOOD THERAPEUTICS IN	65,000	$2.101M	1.9%	$32.32	—	COM	37890U108
—	INVITAE CORP	250,000	$2.053M	1.8%	$8.21	—	COM	46185L103
—	KITE PHARMA INC	30,000	$1.849M	1.6%	$61.63	—	COM	49803L109
DXCM	DEXCOM INC	17,000	$1.392M	1.2%	$20.81	0.0%	COM	252131107
—	BLUEBIRD BIO INC	20,000	$1.284M	1.1%	$64.22	—	Call	09609G100
OSUR	ORASURE TECHNOLOGIES INC	170,000	$1.095M	1.0%	$5.71	0.0%	COM	68554V108
—	OXFORD IMMUNOTEC GLOBAL PLC	75,000	$863K	0.8%	$11.51	—	ORD SHS	G6855A103
—	JUNO THERAPEUTICS INC	17,500	$769K	0.7%	$43.94	—	COM	48205A109
—	ATARA BIOTHERAPEUTICS INC	25,000	$660K	0.6%	$26.40	—	COM	046513107
—	MEDIDATA SOLUTIONS INC	10,000	$493K	0.4%	$49.30	—	COM	58471A105
—	TROVAGENE INC	70,000	$378K	0.3%	$5.40	—	COM NEW	897238309
AGIO	AGIOS PHARMACEUTICALS INC	5,000	$325K	0.3%	$65.59	0.0%	Call	00847X104
—	FOUNDATION MEDICINE INC	15,000	$316K	0.3%	$21.06	—	Call	350465100